Literature DB >> 11687969

Regulation of the human transforming growth factor beta type II receptor gene promoter by novel Sp1 sites.

R Jennings1, M Alsarraj, K L Wright, T Muñoz-Antonia.   

Abstract

The transforming growth factor-beta (TGF beta) type II receptor (T beta R-II) is responsible for transducing the growth inhibitory signals of TGF beta. The T beta R-II gene promoter lacks both a TATA box and a CAAT box near the transcription initiation site, and has been shown to contain binding sequences for several transcription factors (Sp1, AP1, NF-Y, Cut and ERT) which are important for T beta R-II gene promoter activity in vitro. However, it is still not clear which interactions are important for the regulation of T beta R-II gene promoter activity in vivo. Using in vivo genomic DNA footprinting of normal human epithelial cells (HaCaT), we have identified two novel identical and strongly protected sites (ggggctgg) at positions -59 and -102 of the T beta R-II gene promoter. Mutation of either site significantly reduced promoter activity in transient transfections. Protein binding to these sites, as determined by electrophoretic mobility shift assays (EMSA), was specifically competed with consensus Sp1 oligonucleotides. Furthermore, anti-Sp1/3 antibodies produced band shifts when incubated with the T beta R-II -59 and -102 DNA probes. Importantly, Sp1 protein binding was influenced by the presence of an intact NF-Y binding site at position -83. Our data suggests that both Sp1 and NF-Y may play an important role in regulating T beta R-II gene promoter basal activity in vivo.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11687969     DOI: 10.1038/sj.onc.1204808

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  NF-Ya activates multiple hematopoietic stem cell (HSC) regulatory genes and promotes HSC self-renewal.

Authors:  Jiang Zhu; Yi Zhang; Gerard J Joe; Richard Pompetti; Stephen G Emerson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-04       Impact factor: 11.205

2.  Therapeutic effects of the Sp1 inhibitor mithramycin A in glioblastoma.

Authors:  Janina Seznec; Björn Silkenstedt; Ulrike Naumann
Journal:  J Neurooncol       Date:  2010-06-17       Impact factor: 4.130

3.  Elucidating the mechanism of regulation of transforming growth factor β Type II receptor expression in human lung cancer cell lines.

Authors:  Sunil K Halder; Yong-Jig Cho; Arunima Datta; Govindaraj Anumanthan; Amy-Joan L Ham; David P Carbone; Pran K Datta
Journal:  Neoplasia       Date:  2011-10       Impact factor: 5.715

4.  Genomic signatures of breast cancer metastasis.

Authors:  V Urquidi; S Goodison
Journal:  Cytogenet Genome Res       Date:  2007       Impact factor: 1.636

5.  KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor.

Authors:  Daniel L Di Bartolo; Mark Cannon; Yi-Fang Liu; Rolf Renne; Amy Chadburn; Chris Boshoff; Ethel Cesarman
Journal:  Blood       Date:  2008-01-16       Impact factor: 22.113

6.  Modulation of transforming growth factor beta signalling pathway genes by transforming growth factor beta in human osteoarthritic chondrocytes: involvement of Sp1 in both early and late response cells to transforming growth factor beta.

Authors:  Catherine Baugé; Olivier Cauvard; Sylvain Leclercq; Philippe Galéra; Karim Boumédiene
Journal:  Arthritis Res Ther       Date:  2011-02-15       Impact factor: 5.156

7.  Branched-chain amino acids prevent hepatic fibrosis and development of hepatocellular carcinoma in a non-alcoholic steatohepatitis mouse model.

Authors:  Kai Takegoshi; Masao Honda; Hikari Okada; Riuta Takabatake; Naoto Matsuzawa-Nagata; Jean S Campbell; Masashi Nishikawa; Tetsuro Shimakami; Takayoshi Shirasaki; Yoshio Sakai; Taro Yamashita; Toshinari Takamura; Takuji Tanaka; Shuichi Kaneko
Journal:  Oncotarget       Date:  2017-03-14

8.  Silencing of the transforming growth factor-beta (TGFbeta) receptor II by Kruppel-like factor 14 underscores the importance of a negative feedback mechanism in TGFbeta signaling.

Authors:  Mark J Truty; Gwen Lomberk; Martin E Fernandez-Zapico; Raul Urrutia
Journal:  J Biol Chem       Date:  2008-12-15       Impact factor: 5.157

9.  NFkappaB mediates IL-1beta-induced down-regulation of TbetaRII through the modulation of Sp3 expression.

Authors:  C Baugé; G Beauchef; S Leclercq; S J Kim; J P Pujol; P Galéra; K Boumédiene
Journal:  J Cell Mol Med       Date:  2007-12-10       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.